Forefront Analytics LLC purchased a new position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 19,982 shares of the technology company’s stock, valued at approximately $117,000. A number of other large investors have also made changes to their positions in COGT. AJOVista LLC acquired […]
Cogent Biosciences (NASDAQ:COGT) Shares Down 6.1% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Cogent Biosciences Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, has appointed Cole Pinnow as chief commercial officer.
Wedbush reaffirmed their neutral rating on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a report issued on Friday morning, Benzinga reports. They currently have a $10.00 price target on the technology company’s stock. A number of other research analysts have also commented on the company. Leerink Partnrs reiterated an outperform rating on shares […]